Do mast cells hold the key to chronic and unexplained disease?

Jun 01, 2016



Cytology of a mast cell. Image credit: Rayya the Vet, via NIH Image Gallery. 

Dr. Jennifer McClure reflects on evidence about mast cells as a key to chronic disease, providing new insights for physicians, researchers, and the public.

by Jennifer McClure, PhD, Group Health Research Institute Senior Investigator and Director of Research, Faculty & Development

I recently read Never Bet Against Occam: Mast Cell Activation Disease and the Modern Epidemics of Chronic Illness and Medical Complexity, by Dr. Lawrence Afrin. Dr. Afrin is a hematologist at the University of Minnesota, but he may more accurately be called a medical detective and pioneer in the identification and treatment of mast cell activation syndrome (MCAS). Dr. Afrin is one of many physicians and researchers who now believe MCAS may explain some of the most complex cases of chronic disease, not to mention the rising number of patients with chronic illness.

Never heard of MCAS? You’re not alone, which is what makes this story so incredible.

What is MCAS?

Doctors know that mast cells are part of the immune system, but they might not know about MCAS, which was only recently recognized as one of two forms of mast cell activation disease. The better-known form, mastocytosis, is very rare and results from too many mast cells. In contrast, people with MCAS have a normal number of mast cells, but those cells behave badly. In addition to responding to common allergens, in MCAS the mast cells can be hyper-responsive to otherwise non-threatening stimuli, even foods, smells, and physical or emotional stressors. We don’t yet know how common MCAS is, but preliminary research suggests it may affect one in six people (~17 percent).

Why is rogue mast cell activation bad?

When activated, mast cells release many chemicals (such as histamine, heparin, leukotrienes, cytokines, and many others). These chemicals directly or indirectly cause a host of responses in the body including (but not limited to) inflammation, pain, and slow wound healing. Chronic inflammation is as an important underlying cause of chronic disease, since prolonged inflammation can damage the body and is even implicated in some neuropsychiatric illness. By constantly causing inflammation and other reactions in the body, chronic mast cell activation can wreak havoc. And because mast cells are located throughout the body, this havoc can appear just about anywhere.

What should providers know about MCAS?  

If Dr. Afrin and his colleagues are correct,  MCAS should always be suspected in people with poorly explained chronic, multisystem disease, particularly when allergic symptoms or inflammation are involved. Dr. Afrin’s book also nicely illustrates how frustrating this condition is for patients and providers because MCAS can look different in each person and a patient’s symptoms can change over time as different organ systems are affected. It appears that MCAS is more prevalent in females than males (3:1).

What does the future hold for MCAS?

In time, we will learn more about the underlying cause of MCAS (current thinking attributes it to one or more genetic mutations), how to effectively manage the disease, and perhaps even how to cure it. In the meantime, Dr. Afrin and his colleagues want to raise awareness of MCAS among the medical community and patients living with chronic disease. With this awareness will come the necessary funding, research, and knowledge needed to help us reduce the pain and suffering experienced by those living with chronic disease due to MCAS.  

What does this mean for GHRI?

If MCAS is as common as suggested, many people—including many Group Health members—could be affected. GHRI is well positioned to contribute to future studies of MCAS given the size of our patient population, our access to comprehensive medical records from primary and specialty care, and our leading scientists in epidemiology and chronic disease management. 

I encourage physicians, scientists, and anyone interested in chronic disease to learn more about this exciting new area. 

Suggested reading

Afrin, L. Never Bet Against Occam: Mast Cell Activation Disease and the Modern Epidemics of Chronic Illness and Medical Complexity. (2016). Sisters Media, Bethesda, MD.

Afrin L, Butterfield JH, Raithel M, and Molderings GJ. Often seen, rarely recognized: mast cell activation disease—a guide to diagnosis and therapeutic options. Annals of Medicine, 48(3):190-201.

Afrin L.  (March 2016). A new era for an old cell: heightened appreciation of mast cell disease emerges. Translational Research. [Epub ahead of print]. 

Please add a comment

Please note: Any health or personal information you choose to disclose in your comment will be publicly viewable. Also, GHRI’s posting of your comment does not constitute its endorsement. For more information, read our blog posting guidelines and our site Terms of Use and Privacy Policy.
Posted by Mark on
1. How is chronic disease manifesting as a Systemic Mast Cell Disorder "Unexplained"?

2. MCAS new? Vanderbilt pioneers documented at a conference published over a quarter century ago that most patients presenting there w/ the clinical presentation of ("Indolent") Systemic Mastocytosis -- manifesting "clinically identical"signs from similar range of excessive MC "mediator" activity, similar array of triggers, warranting similar pracautiond, regimens of MC "stabilizers"; antihistamines and other drugs to combat harm from excessive mediators; corticosteroids, epinephrine; as necessary.
3.> "we will learn more about the underlying cause of MCAS (current thinking attributes it to one or more genetic mutations)"? That describes some of the cutting edge research/analysis." What establishes MCAS has but one "underlying" cause?Anyone with the constellation of consensus clinical signs defining recurrent Anaphylaxis (including clinically identical Anaphlactoid reactions) to a range of (MC) triggers -- and/or recurrent urticaria/angioedema w/ signs manifesting associated chronic, systemic "mediator" activity -- suffers Systemic Mast Cell Disorder/Syndrome essentially by definition. See, e.g. http://www.mastopedia.com/tiki-index.phppage=Systemic+Mast+Cell+Activation+Disorder%3A++the+revised+version+of+the+International+Classification+of+Diseases+should+include+a+distinct+ICD-11+code+for+SMCAD and accompanying cited authorities, including back to a 1982 AMA journal article.
Posted by Linda Simmons on
Dr Afrin has treat my daughter who has severe mast cell disease with so much kindness and patience, sadly she has not tolerated any of the treatments I am sure she would have died already as she has had 2 cardiac arrest while in the hospital when some doctors under treat this disease He is so smart and continues to try to help my child and many more like her
Posted by Rosemary Small on
With a persistent unrelenting whole body rash barely controlled by steroids, developing gastrointestinal issues, over 35 years of arthritis and a genetic autoimmune condition HEDS ,it hits me daily that something unexplained is going on. Is it MCAS? Is this on my physician,s radar or any physician's radar. If I bring it up as a possibility will they laugh it off or even know how to explore it? Will the care avenue needed be like all the other useful treatments for my condition on my dime, because the insurance company severely limits effective treatment due to cost because they consider these issues experimental or too expensive to cover? My debt for treatments on my dime are huge.
Posted by Jennifer McClure on
Thanks for sharing your story. It is a good example why we need to learn more about MCAS and how to more effectively treat chronic mast cell activation. I hope this article can help raise awareness for your daughter and others!
Posted by Roberta Maguire on
I have had Chronic Fatigue Syndrome/ME/Exertion Intolerance/Fibromyalgia, or whatever you call it, since 1985, plus recent bouts of inflammation. Needless to say, I will be most interested in any Mast Cell information that might arise out of research, and would hope researchers include this "unexplained" illness in their searches.
Posted by Mary Matzke on
My 21 year-old daughter has been suffering for 5 years with MCAS symptom which were finally diagnosed by Dr. Afrin. He is an amazing, brilliant and compassionate physician who generously communicates with physicians working with patients he has seen for diagnosis. When my daughter and I were suspecting MCAS based on our own research, and she had been hospitalized with severe abdominal pain for hundreds of days without any explanation, I was told by a group of physicians as Childrens' Hospital Los Angeles that I must "stop looking for a diagnosis - my daughter just had pain - I was harming her by not accepting that reality and continuing to go to doctors to find a reason for it". Thank God I did not listen to them. We even brought up the MCAS possibility but the allergist there told us that because one lab (tryptase) value was not elevated (which is generally only elevated with mastocytosis), she couldn't have mast cell disease. How wrong he was. I know my daughter is not alone in her struggle to find a correct diagnosis, and in the process has been mis-diagnosed as well as labeled as a "drug seeker" and psychiatric patient. Please keep up your efforts to educate the medical community on this not-so-rare illness.
Leave a reply

(Your e-mail address will not be publicly displayed.)